PRME- Prime Medicine, Inc.

Name: Prime Medicine, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Prime Medicine, Inc. (PRME) has 14 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. PRME is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Liu David R.	20.24M	$64.97M	-
10%	Nelsen Robert	6.23M	$20.00M	-
10%	Arch Venture Partners Xii, LLC	6.23M	$20.00M	-
10%	Arch Venture Partners X, LLC	6.23M	$20.00M	-
Other	Lee Ann L.	181.0K	$581.0K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 1, 2025	Nelsen Robert	Director, 10% Owner	Buy	3,030,300	$3.30	$9,999,990.00	+94.7%	+7.7%	-
Aug 1, 2025	Arch Venture Partners Xii, LLC63	10% Owner	Buy	3,030,300	$3.30	$9,999,990.00	+94.7%	+7.7%	-
Aug 1, 2025	Arch Venture Partners X, LLC	10% Owner	Buy	3,030,300	$3.30	$9,999,990.00	+94.7%	+7.7%	-
Jun 30, 2025	Liu David R.71	10% Owner	Buy	21,000	$2.52	$52,829.70	+0.1%	+115.4%	-
Jun 23, 2025	Liu David R.71	10% Owner	Buy	21,000	$2.16	$45,402.00	+0.1%	+131.0%	-
Jun 16, 2025	Liu David R.71	10% Owner	Buy	21,000	$1.49	$31,195.50	+0.1%	+167.3%	-
Jun 11, 2025	Liu David R.71	10% Owner	Buy	21,000	$1.60	$33,589.50	+0.1%	+169.3%	-
May 21, 2025	Lee Ann L.	Chief Technical Officer	Buy	100,000	$1.13	$113,000.00	New	+178.1%	-
May 21, 2025	Reine Allan	Chief Executive Officer	Buy	125,000	$1.18	$147,150.00	New	+178.1%	-
May 20, 2025	Brudnick Richard	Chief Business Officer	Buy	20,000	$1.19	$23,790.00	New	+197.9%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC